Varenicline-d4hydrochloride is a deuterium-labeled form of Varenicline (dihydrochloride). Varenicline (CP 526555) dihydrochloride acts as a partial agonist for the alpha4beta2 nicotinic acetylcholine receptor (alpha4beta2nAChR), with an EC50 of 2.3 µM. It serves as a full agonist for alpha3beta4nAChR and alpha7nAChR, with EC50 values of 55 µM and 18 µM, respectively. As a nicotine ligand based on a cytosine structure, Varenicline dihydrochloride is utilized in smoking cessation research.
Target:
AChR
* VAT and and shipping costs not included. Errors and price changes excepted
